Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab for Nail Psoriasis
NCT02016482Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Jan 2014
- Primary completion
- Oct 2015
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of adalimumab in nail psoriasis, sponsored by AbbVie Inc.. Started Jan 2014; status: completed.
02
Drugs
03
Conditions
nail psoriasis
Beyond the preview
Go deeper on NCT02016482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02016482.